COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,026 Articles (22,627 medRxiv, 8,399 bioRxiv)

Most recent first Previous |  Page 2367: Articles 23661-23670  | Next

SCV-2000bp: a primer panel for SARS-CoV-2 full-genome sequencing
Speranskaya, A., Kaptelova, V., Valdokhina, A., Bulanenko, V., Samoilov, A., Korneenko, E., Shipulina, O., Akimkin, V.
10.1101/2020.08.04.234880 — Posted: 2020-08-04
A valid protective immune response elicited in rhesus macaques by an inactivated vaccine is capable of defending against SARS-CoV-2 infection
Chen, H., Xie, Z., Long, R., Fan, S., Li, H., He, Z., Xu, K., Liao, Y., Wang, L., Zhang, Y., Li, X., Dong, X., Mou, T., Zhou, X., Yang, Y., Guo, L., Yang, J., Zheng, H., Xu, X., Li, J., Liang, Y., Li, D., Zhao, Z., Hong, C., Zhao, H., Jiang, G., Che, Y., Yang, F., Hu, Y., Wang, X., Pu, J., Ma, K., Wang, L., Chen, C., Duan, W., Shen, D., Zhao, H., Jiang, R., Deng, X., Li, Y., Zhu, H., Zhou, J., Yu, L., Xu, M., Yang, H., Yi, L., Zhou, Z., Yang, J., Duan, N., Yang, H., Zhao, W., Yang, W., Li, C., Liu, L., Li, Q.
10.1101/2020.08.04.235747 — Posted: 2020-08-04
A distinct innate immune signature marks progression from mild to severe COVID-19
Chevrier, S., Zurbuchen, Y., Cervia, C., Adamo, S., Raeber, M. E., de Souza, N., Sivapatham, S., Jacobs, A., Bächli, E., Rudiger, A., Stüssi-Helbling, M., Huber, L. C., Schaer, D. J., Nilsson, J., Boyman, O., Bodenmiller, B.
10.1101/2020.08.04.236315 — Posted: 2020-08-04
Lymphopenia-induced T cell proliferation is a hallmark of severe COVID-19
Adamo, S., Chevrier, S., Cervia, C., Zurbuchen, Y., Räber, M. E., Yang, L., Sivapatham, S., Jacobs, A., Bächli, E., Rudiger, A., Stüssi-Helbling, M., Huber, L. C., Schaer, D., Bodenmiller, B., Boyman, O., Nilsson, J.
10.1101/2020.08.04.236521 — Posted: 2020-08-04 Discussion: Onsite | Offsite
SARS-CoV-2 infection, disease and transmission in domestic cats
Gaudreault, N. N., Trujillo, J. D., Carossino, M., Meekins, D. A., Morozov, I., Madden, D. W., Indran, S. V., Bold, D., Balaraman, V., Kwon, T., Libanori Artiaga, B., Cool, K., Garcia-Sastre, A., Ma, W., Wilson, W. C., Henningson, J., Balasuriya, U. B., Richt, J. A.
10.1101/2020.08.04.235002 — Posted: 2020-08-04
Binding Ligands that Straddle an Important Contact Site on the RBD of the Covid-19 Spike Protein
Boyarsky, A.
10.1101/2020.08.03.234989 — Posted: 2020-08-04 Discussion: Onsite
Analysis of COVID-19 and comorbidity co-infection Model with Optimal Control
Omame, D. A., Ikenna, N.
10.1101/2020.08.04.20168013 — Posted: 2020-08-04
SalivaDirect: Simple and sensitive molecular diagnostic test for SARS-CoV-2 surveillance
Vogels, C. B. F., Brackney, D., Wang, J., Kalinich, C. C., Ott, I., Kudo, E., Lu, P., Venkataraman, A., Tokuyama, M., Moore, A. J., Muenker, M. C., Casanovas-Massana, A., Fournier, J., Bermejo, S., Campbell, M., Datta, R., Nelson, A., Yale IMPACT Research Team, , Dela Cruz, C., Farhadian, S., Ko, A., Iwasaki, A., Hui, P., Liu, C., Wyllie, A. L., Grubaugh, N.
10.1101/2020.08.03.20167791 — Posted: 2020-08-04 Discussion: Onsite
Fitting models to the COVID-19 outbreak and estimating R
Keeling, M. J., Dyson, L., Guyver-Fletcher, G., Holmes, A., Semple, M. G., ISARIC4C Investigators, , Tildesley, M. J., Hill, E. M.
10.1101/2020.08.04.20163782 — Posted: 2020-08-04 Discussion: Onsite
Assessment of multiplex digital droplet RT-PCR as an accurate diagnosis tool for SARS-CoV-2 detection in nasopharyngeal swabs and saliva samples
CASSINARI, K., Alessandri, E., Chambon, P., Charbonnier, F., Gracias, S., Beaussire, L., Alexandre, K., Sarafan-Vasseur, N., Houdayer, C., Etienne, M., Caron, F., Plantier, J.-C., Frebourg, T.
10.1101/2020.08.02.20166694 — Posted: 2020-08-04 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).